EP4475853A4 - Zusammensetzungen und verfahren zur behandlung und prävention von erkrankungen mit titilazadsalzen - Google Patents

Zusammensetzungen und verfahren zur behandlung und prävention von erkrankungen mit titilazadsalzen

Info

Publication number
EP4475853A4
EP4475853A4 EP23753569.5A EP23753569A EP4475853A4 EP 4475853 A4 EP4475853 A4 EP 4475853A4 EP 23753569 A EP23753569 A EP 23753569A EP 4475853 A4 EP4475853 A4 EP 4475853A4
Authority
EP
European Patent Office
Prior art keywords
tirilazad
prevention
salts
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23753569.5A
Other languages
English (en)
French (fr)
Other versions
EP4475853A1 (de
Inventor
Patrick T Prendergast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2023/061743 external-priority patent/WO2023154647A1/en
Publication of EP4475853A1 publication Critical patent/EP4475853A1/de
Publication of EP4475853A4 publication Critical patent/EP4475853A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP23753569.5A 2022-02-09 2023-02-01 Zusammensetzungen und verfahren zur behandlung und prävention von erkrankungen mit titilazadsalzen Pending EP4475853A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IES20220049 2022-02-09
PCT/US2023/061743 WO2023154647A1 (en) 2022-02-09 2023-02-01 Compositions and methods for treatment and prevention of diseases utilizing tirilazad salts

Publications (2)

Publication Number Publication Date
EP4475853A1 EP4475853A1 (de) 2024-12-18
EP4475853A4 true EP4475853A4 (de) 2026-03-04

Family

ID=93561791

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23753569.5A Pending EP4475853A4 (de) 2022-02-09 2023-02-01 Zusammensetzungen und verfahren zur behandlung und prävention von erkrankungen mit titilazadsalzen

Country Status (1)

Country Link
EP (1) EP4475853A4 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0238545B1 (de) * 1985-09-12 1995-11-15 The Upjohn Company C20 bis C26 Aminosteroide
US20200031907A1 (en) * 2014-10-15 2020-01-30 Prendergast Patrick T Compositions and methods for treatment of diseases
EP3721882A1 (de) * 2014-04-01 2020-10-14 Boehringer Ingelheim Vetmedica GmbH Behandlung von stoffwechselerkrankungen bei pferden

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0238545B1 (de) * 1985-09-12 1995-11-15 The Upjohn Company C20 bis C26 Aminosteroide
EP3721882A1 (de) * 2014-04-01 2020-10-14 Boehringer Ingelheim Vetmedica GmbH Behandlung von stoffwechselerkrankungen bei pferden
US20200031907A1 (en) * 2014-10-15 2020-01-30 Prendergast Patrick T Compositions and methods for treatment of diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2023154647A1 *

Also Published As

Publication number Publication date
EP4475853A1 (de) 2024-12-18

Similar Documents

Publication Publication Date Title
PT3861985T (pt) Composições e métodos para tratar doenças oculares
EP4054713A4 (de) Zusammensetzungen und verfahren zur behandlung oder vorbeugung von hautkrankheiten und störungen mit lekti
IL287802A (en) Preparations and methods for the treatment of eye diseases
PL3848024T3 (pl) Kompozycje obejmujące aminokwasy do zapobiegania i/lub leczenia nowotworów
EP4284272A4 (de) Zusammensetzungen und verfahren zur verzögerten behandlung von schmerzen
IL312583A (en) A preparation for the treatment and prevention of COVID-19
EP4135661A4 (de) Zusammensetzungen und verfahren zur behandlung von neurologischen erkrankungen
EP4475853A4 (de) Zusammensetzungen und verfahren zur behandlung und prävention von erkrankungen mit titilazadsalzen
HUE067796T2 (hu) Összetételek és eljárások betegségek kezelésére
IL305766A (en) Preparations for the treatment and prevention of behavioral disorders
HK40105820A (en) Methods and compositions for treatment of disease
EP4304624A4 (de) Verfahren und zusammensetzungen zur behandlung von krankheiten
HK40130645A (zh) 用於治疗神经退行性疾病的多核苷酸组合物和方法
HK40115052A (en) Compositions and methods for treatment of prion diseases
CA3288046A1 (en) Compositions and methods for the treatment of skin diseases and conditions including eczema
GB202318443D0 (en) Compositions and methods of treatment
HK40129688A (en) Compositions and methods for treatment of neurodegenerative diseases
CA3269269A1 (en) Compositions and methods for treatment of neurodegenerative diseases
GB202218196D0 (en) Compositions and methods of treatment
CA3293188A1 (en) Compositions and methods for treatment and prevention of neurodegenerative diseases and disorders
CA3280428A1 (en) Compositions and methods for kras inhibition for the treatment of disease
IL316047A (en) Preparations and methods for the treatment of cancer
HK40117406A (en) Compositions and methods for treatment of pain
IL317091A (en) Compositions and methods for treating severe hypertriglyceridemia
PL4117709T3 (pl) Kompozycje i sposoby związane z leczeniem chorób

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240909

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20260130

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/57 20060101AFI20260126BHEP

Ipc: A61K 47/28 20060101ALI20260126BHEP

Ipc: A61K 31/7042 20060101ALI20260126BHEP

Ipc: A61K 31/70 20060101ALI20260126BHEP

Ipc: A61K 31/58 20060101ALI20260126BHEP

Ipc: A61K 31/155 20060101ALI20260126BHEP

Ipc: A61P 1/00 20060101ALI20260126BHEP

Ipc: A61K 45/06 20060101ALI20260126BHEP

Ipc: A61P 17/00 20060101ALI20260126BHEP

Ipc: A61P 19/00 20060101ALI20260126BHEP

Ipc: A61P 29/00 20060101ALI20260126BHEP

Ipc: A61P 37/00 20060101ALI20260126BHEP

Ipc: A61P 43/00 20060101ALI20260126BHEP